![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/SYNCOMF.png)
Share the post "Syncom Formulations (India) ‘s Q3 2024-25 Latest News: Revenue Up by 95.78% Year-on-Year"
Highlights
🔹 The presented financial data is Consolidated to provide a comprehensive overview of the company performance. 🔹 Sales over the Year and quarter: The company experienced a substantial growth of 95.78 % in the past year, substantial increase in net sales/revenue by 24.65 %. 🔹 Income over the Year and quarter: There has been decline in other income over the past year which is -10.9 %, Marginal decrease of -2.7% in other income during this quarter. 🔹 Profit over the Year and quarter: Significant improvement in profitability for Syncom Formulations (India) Limited. Notable increase of 85.69 % in net profit Year to Year, Syncom Formulations (India) Limited’s profitability increased by 17.05 % in this quarter. 🔹 EPS over the Year and quarter: EPS increased by 55.56 % Year to Year. EPS decreased by -12.5 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 65.14 Cr | Rs. 102.314 Cr | Rs. 127.533 Cr | + 24.65 % | + 95.78 % |
| Expenses | Rs. 57.78 Cr | Rs. 90.15 Cr | Rs. 112.8 Cr | + 25.12 % | + 95.22 % |
| Operating Profit | Rs. 7.36 Cr | Rs. 12.16 Cr | Rs. 14.73 Cr | + 21.13 % | + 100.14 % |
| OPM % | 11.3 % | 11.88 % | 11.55 % | -0.33 % | + 0.25 % |
| Other Income | Rs. 4.531 Cr | Rs. 4.149 Cr | Rs. 4.037 Cr | -2.7 % | -10.9 % |
| Interest | Rs. 1.08 Cr | Rs. 0.16 Cr | Rs. 0.2 Cr | + 25 % | -81.48 % |
| Depreciation | Rs. 1.45 Cr | Rs. 1.3 Cr | Rs. 1.31 Cr | + 0.77 % | -9.66 % |
| Profit before tax | Rs. 9.36 Cr | Rs. 14.85 Cr | Rs. 17.26 Cr | + 16.23 % | + 84.4 % |
| Tax % | 25.21 % | 25.2 % | 24.68 % | -0.52 % | -0.53 % |
| Net Profit | Rs. 7 Cr | Rs. 11.11 Cr | Rs. 13 Cr | + 17.01 % | + 85.71 % |
| EPS in Rs | Rs. 0.09 | Rs. 0.16 | Rs. 0.14 | -12.5 % | + 55.56 % |
Today, we’re looking at Syncom Formulations (India) Limited’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 95.78 %. However, it did see a marginal increase of 24.65 % from the previous quarter. Expenses ticked up slightly by 25.12 % quarter-on-quarter, aligning with the annual rise of 95.22 %. Operating profit, while up 100.14 % compared to last year, faced a quarter-on-quarter increase of 21.13 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 0.25 %, but a shrinkage of -0.33 % sequentially. Other income fell by -2.7 % compared to the last quarter, despite an annual decline of -10.9 %. Interest expenses surged remarkably by 25 % from the previous quarter, yet the year-over-year decrease remains at a moderate -81.48 %. Depreciation costs climbed by 0.77 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -9.66 %. Profit before tax grew annually by 84.4 % but saw an increase from the preceding quarter by 16.23 %.
Tax expenses as a percentage of profits decreased slightly by -0.53 % compared to last year, with a more notable quarter-on-quarter decrease of -0.52 %. Net profit rose by 85.71 % year-on-year but experienced a 17.01 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 55.56 % but a quarterly fall of -12.5 %. In summary, Syncom Formulations (India) Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 65.14 Cr | Rs. 102.314 Cr | Rs. 127.533 Cr | + 24.65 % | + 95.78 % |
| Expenses | Rs. 57.78 Cr | Rs. 90.15 Cr | Rs. 112.8 Cr | + 25.12 % | + 95.22 % |
| Operating Profit | Rs. 7.36 Cr | Rs. 12.16 Cr | Rs. 14.73 Cr | + 21.13 % | + 100.14 % |
| Net Profit | Rs. 7 Cr | Rs. 11.11 Cr | Rs. 13 Cr | + 17.01 % | + 85.71 % |
| EPS in Rs | Rs. 0.09 | Rs. 0.16 | Rs. 0.14 | -12.5 % | + 55.56 % |
In reviewing Syncom Formulations (India) Limited’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 95.78 % year-on-year growth, however, there was a minor increase of 24.65 % from the previous quarter. Expenses rose by 95.22 % compared to the previous year, with a 25.12 % increase quarter-on-quarter. Operating Profit surged by 100.14 % annually, and saw a 21.13 % increase from the last quarter.
Net Profit showed yearly increase of 85.71 %, and experienced a 17.01 % increase from the previous quarter. Earnings Per Share (EPS) rose by 55.56 % annually, however dipped by -12.5 % compared to the last quarter. In essence, while Syncom Formulations (India) Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
